AGL 40.00 Decreased By ▼ -0.01 (-0.02%)
AIRLINK 127.00 Decreased By ▼ -0.99 (-0.77%)
BOP 6.68 Increased By ▲ 0.08 (1.21%)
CNERGY 4.49 Decreased By ▼ -0.11 (-2.39%)
DCL 8.60 Increased By ▲ 0.12 (1.42%)
DFML 41.30 Decreased By ▼ -0.18 (-0.43%)
DGKC 86.71 Increased By ▲ 0.13 (0.15%)
FCCL 32.16 Increased By ▲ 0.02 (0.06%)
FFBL 64.70 Decreased By ▼ -0.72 (-1.1%)
FFL 10.29 Increased By ▲ 0.04 (0.39%)
HUBC 109.51 Decreased By ▼ -0.98 (-0.89%)
HUMNL 14.90 Increased By ▲ 0.15 (1.02%)
KEL 5.05 Decreased By ▼ -0.08 (-1.56%)
KOSM 7.40 Increased By ▲ 0.28 (3.93%)
MLCF 41.39 Decreased By ▼ -0.26 (-0.62%)
NBP 60.60 Increased By ▲ 0.51 (0.85%)
OGDC 190.00 Decreased By ▼ -4.69 (-2.41%)
PAEL 27.81 Decreased By ▼ -0.14 (-0.5%)
PIBTL 7.75 Decreased By ▼ -0.25 (-3.13%)
PPL 149.75 Decreased By ▼ -1.42 (-0.94%)
PRL 26.73 Decreased By ▼ -0.15 (-0.56%)
PTC 16.18 Increased By ▲ 0.18 (1.13%)
SEARL 86.02 Increased By ▲ 7.82 (10%)
TELE 7.72 Increased By ▲ 0.33 (4.47%)
TOMCL 35.58 Decreased By ▼ -0.09 (-0.25%)
TPLP 8.14 Increased By ▲ 0.23 (2.91%)
TREET 16.51 Increased By ▲ 0.62 (3.9%)
TRG 53.35 Increased By ▲ 0.59 (1.12%)
UNITY 26.28 Decreased By ▼ -0.27 (-1.02%)
WTL 1.26 Decreased By ▼ -0.01 (-0.79%)
BR100 9,889 Decreased By -31.1 (-0.31%)
BR30 30,611 Decreased By -140.9 (-0.46%)
KSE100 93,355 Increased By 130.9 (0.14%)
KSE30 28,931 Increased By 46 (0.16%)
Markets

Gold falls to 4-month low as vaccine hopes take centre stage

  • Spot gold was down 0.7pc at $1,823.58 per ounce at 1015 GMT, having earlier slid to its lowest since July 21 at $1,820.45. It slumped as much as 2.2pc on Monday.
Published November 24, 2020

Gold slid to a four-month low on Tuesday, extending a sharp slide from the previous session, as optimism over the development of COVID-19 vaccines drove investors to riskier assets.

Spot gold was down 0.7pc at $1,823.58 per ounce at 1015 GMT, having earlier slid to its lowest since July 21 at $1,820.45. It slumped as much as 2.2pc on Monday.

U.S. gold futures dipped 0.9pc to $1,820.60.

European equities rose on a possible easing of COVID-19 curbs and progress on AstraZeneca's vaccine, which joined other major drugmakers to declare positive test results.

"We had news about the vaccine, saw yields moving higher in U.S., even the dollar went lower and gold is not profiting from that ... This is a very bad sign for gold and means there is an underlying weakness building up," said ABN Amro analyst Georgette Boele.

A break below crucial support of $1,800 would trigger further price declines, Boele added.

The dollar held close to a near three-month low, potentially making gold cheaper for those holding other currencies.

In another boost to risk sentiment, U.S. President-elect Joe Biden was given the go-ahead to begin his White House transition.

"The acknowledgement of Biden's victory from the Republicans is likely to reduce the risk of further tensions and represents a supportive element for stocks, while haven assets such as gold are suffering," ActivTrades' chief analyst, Carlo Alberto De Casa, said in a note.

But "despite the dominant risk-on scenario, central banks will still be forced to print a huge amount of money and this could revamp investors' interest for gold in the near future."

Gold is considered a hedge against inflation and currency debasement, likely to result from the unprecedented stimulus unleashed globally to fight the pandemic's economic toll.

Silver fell 0.9pc to $23.37 an ounce.

Platinum rose 1.1pc to $936.11, while palladium dropped 1pc to $2,331.06.

Comments

Comments are closed.